Alphazyme press releases
6/20/24 9:15 am EST
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company (NASDAQ:MRVI) and global provider of specialty enzymes used in the life sciences sector, announced the successful conclusion of the companies' previously announced Linea™ RNAP manufacturing scale-up agreement.
More Information
3/18/24 9:00 am EST
Applied DNA Enters into Agreement with Alphazyme
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
More Information
1/5/22 9:00 am EST
Alphazyme to Attend AGBT
Alphazyme is attending AGBT (https://www.agbt.org/) February 6th to February 9th Hollywood, FL. Would you like to meetup at the conference? Contact us at info@alpha-zymes.com or 888-725-5635.
11/15/22 8:15 am EST
Alphazyme Is Now ISO 13485:2016 Certified
Alphazyme has been awarded certification to the ISO 13485:2016 Quality Management System (QMS) standard by British Standards International (BSI). Contact us at info@alpha-zyme.com or 888-725-5635.
More Information
9/28/20 8:15 am EST
Dyadic Reaches Agreement with Alphazyme
Dyadic Announces Sub-Licensing Agreement with Alphazyme.
More Information
6/2/20 8:15 am EST
Codexis and Alphazyme Join Forces
Alphazyme is attending AGBT (https://www.agbt.org/) February 6th to February 9th Hollywood, FL. Would you like to meetup at the conference? Contact us at info@alpha-zymes.com or 888-725-5635.